Literature DB >> 34337426

Living Organ Donor Perspectives and Sources of Hesitancy about COVID-19 Vaccines.

Meera N Harhay1,2,3, Ann C Klassen4, Hasan Zaidi1, Michael Mittelman5, Rebecca Bertha5, Roslyn B Mannon6, Krista L Lentine7.   

Abstract

BACKGROUND: Living organ donation declined substantially in the United States during the COVID-19 pandemic due to concerns about donor and transplant candidate safety. COVID-19 vaccines might increase confidence in the safety of living organ donation during the pandemic. We assessed informational preferences and perspectives about COVID-19 vaccines among US living organ donors and prospective donors.
METHODS: We conducted a national survey study of organ donors and prospective donors on social media platforms between 12/28/2020-2/23/2021. Survey items included multiple choice, visual analog scale, and open-ended responses. We examined associations between information preferences, history of COVID-19 infection, influenza vaccination history and COVID-19 vaccine acceptance using multivariable logistic regression and performed a thematic analysis of open-ended responses.
RESULTS: Among 342 respondents from 47 US states and the District of Columbia, 35% were between 51-70 years old, 90% were non-Hispanic white, 87% were women; 82% were living donors (94% kidney) and 18% in evaluation to donate (75% kidney).The majority planned to or had received COVID-19 vaccination (76%), whereas 11% did not plan to be receive a vaccine, and 12% were unsure. Adjusting for demographics and donor characteristics, respondents who receive yearly influenza vaccinations had higher COVID-19 vaccine acceptance than those who do not (adjusted Odds Ratio [aOR] 5.06, 95% Confidence Interval [CI] 2.68-9.53). Compared to respondents who prioritized medical information sources (e.g., personal physicians and transplant providers), those who prioritized news and social media had lower COVID-19 vaccine acceptance (aOR 0.34, 95% CI 0.15-0.73). Low perceived personal benefit from vaccination and uncertainty about long-term safety were common themes among those declining COVID-19 vaccines.
CONCLUSIONS: Donor informational source preferences were strongly associated with the likelihood of accepting a COVID-19 vaccine. Vaccine guidance for organ donors who are unsure about COVID-19 vaccines could incorporate messaging about safety and benefits of vaccination for healthy people.

Entities:  

Keywords:  COVID-19; kidney transplant; liver transplant; living donor; organ donation; vaccines

Mesh:

Substances:

Year:  2021        PMID: 34337426      PMCID: PMC8323843          DOI: 10.34067/kid.0002112021

Source DB:  PubMed          Journal:  Kidney360        ISSN: 2641-7650


  11 in total

1.  Best practices in mixed methods for quality of life research.

Authors:  Ann C Klassen; John Creswell; Vicki L Plano Clark; Katherine Clegg Smith; Helen I Meissner
Journal:  Qual Life Res       Date:  2012-02-04       Impact factor: 4.147

2.  Vaccine hesitancy: Definition, scope and determinants.

Authors:  Noni E MacDonald
Journal:  Vaccine       Date:  2015-04-17       Impact factor: 3.641

Review 3.  Clinical applications of visual analogue scales: a critical review.

Authors:  H M McCormack; D J Horne; S Sheather
Journal:  Psychol Med       Date:  1988-11       Impact factor: 7.723

Review 4.  Risks and outcomes of living donation.

Authors:  Krista L Lentine; Anita Patel
Journal:  Adv Chronic Kidney Dis       Date:  2012-07       Impact factor: 3.620

5.  Estimating predicted probabilities from logistic regression: different methods correspond to different target populations.

Authors:  Clemma J Muller; Richard F MacLehose
Journal:  Int J Epidemiol       Date:  2014-03-05       Impact factor: 7.196

Review 6.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

7.  Survey of US Living Kidney Donation and Transplantation Practices in the COVID-19 Era.

Authors:  Krista L Lentine; Luke S Vest; Mark A Schnitzler; Roslyn B Mannon; Vineeta Kumar; Mona D Doshi; Matthew Cooper; Didier A Mandelbrot; Meera N Harhay; Michelle A Josephson; Yasar Caliskan; Asif Sharfuddin; Bertram L Kasiske; David A Axelrod
Journal:  Kidney Int Rep       Date:  2020-08-25

8.  Surveillance of Vaccination Coverage among Adult Populations - United States, 2015.

Authors:  Walter W Williams; Peng-Jun Lu; Alissa O'Halloran; David K Kim; Lisa A Grohskopf; Tamara Pilishvili; Tami H Skoff; Noele P Nelson; Rafael Harpaz; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Amy Parker Fiebelkorn
Journal:  MMWR Surveill Summ       Date:  2017-05-05

9.  American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.

Authors:  Oren K Fix; Robert J Fontana; Emily A Blumberg; Kyong-Mi Chang; Jaime Chu; Raymond T Chung; Elizabeth K Goacher; Bilal Hameed; Daniel R Kaul; Laura M Kulik; Ryan M Kwok; Brendan M McGuire; David C Mulligan; Jennifer C Price; Nancy S Reau; K Rajender Reddy; Andrew Reynolds; Hugo R Rosen; Mark W Russo; Michael L Schilsky; Elizabeth C Verna; John W Ward
Journal:  Hepatology       Date:  2021-08       Impact factor: 17.298

10.  Early impact of COVID-19 on transplant center practices and policies in the United States.

Authors:  Brian J Boyarsky; Teresa Po-Yu Chiang; William A Werbel; Christine M Durand; Robin K Avery; Samantha N Getsin; Kyle R Jackson; Amber B Kernodle; Sarah E Van Pilsum Rasmussen; Allan B Massie; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  Am J Transplant       Date:  2020-05-10       Impact factor: 9.369

View more
  1 in total

Review 1.  Multilevel determinants of COVID-19 vaccination hesitancy in the United States: a rapid systematic review.

Authors:  Ying Wang; Yu Liu
Journal:  Prev Med Rep       Date:  2021-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.